Bronchial Thermoplasty Catheter Market Report
Bronchial Thermoplasty Catheter Market by End User (Hospitals and Ambulatory Surgery Centers): Global Opportunity Analysis and Industry Forecast, 2022-2031
Global Bronchial Thermoplasty Catheter Market Analysis
The Global Bronchial Thermoplasty Catheter Market Size was $3,409 million in 2021 and is predicted to grow with a CAGR of 4.99%, by generating a revenue of $5,416.8 million by 2031.
Global Bronchial Thermoplasty Catheter Market Synopsis
Asthma is the most common non-communicable disease in children and one of the most common chronic diseases in adulthood. It is a major global health problem. People with asthma have chronic inflammation in their airways. During an asthma attack, the smooth muscle that lines the lungs swells even more. People in the 30 to 50 age group who have severe asthma choose bronchial thermoplasty as the best treatment option as per advice by specialists. This has resulted in the growth of the bronchial thermoplasty catheter market globally. Bronchial thermography (BT) reduces ASM (airway smooth muscle) and relieves symptoms in this treatment. Additionally, the asthma patients' quality of life is enhanced by BT because it reduces ASM (Airway Smooth Muscle), bronchoconstriction, and asthma exacerbations. Three sessions are required for bronchial thermoplasty treatment, each separated by at least three weeks. The right lower lobe of airways is treated in the first session, the left lower lobe in the second, and then both upper lobes in the third. Increasing geriatric population and growing number of hospitals are two major growth drivers for this market.
The bronchial thermoplasty treatment has some possible side effects that might come after the procedure such as chest tightness and wheezing. People may experience a brief wheezing problem after the treatment, but it typically resolves within a week. The bronchial thermoplasty catheter market growth is expected to be hampered by these side effects of bronchial thermoplasty treatment.
Bronchial thermoplasty is an outpatient procedure that treats severe asthma by addressing it at the source. It utilizes a probe that generates heat and causes scarred, thickened lung tissue to shrink. Bronchial thermoplasty has been shown to reduce asthma attacks for at least 5 years. The increase in the rate of asthma, as well as the rise in pollution and dust allergy problems, are the primary opportunity for the bronchial thermoplasty industry. Additionally, the growth rate of the bronchial thermoplasty catheter market share will be significantly affected by the growing number of government initiatives to raise public awareness. Advancements in technology is another important opportunity to the growth of the market.
Region-wise, the North America bronchial thermoplasty catheter market accounted a dominating market share in 2021. Increasing asthma attacks among individuals, increase in the number of hospitalizations of asthma patients in the U.S, the presence of major players in the region, and rapid technological advancements are some of the factors that have contributed to the growth of the bronchial thermoplasty market in the North America region.
Bronchial Thermoplasty Catheter Overview
Bronchial thermoplasty is a treatment option for asthma patients that helps to avoid persistent structural alterations in the airway smooth muscle (ASM). Bronchial thermoplasty is an asthma treatment that targets the smooth muscle in the lungs as well as bronchoconstriction and asthma exacerbations, improving an asthma patient's quality of life. Bronchial thermoplasty enables the precise delivery of radiofrequency radiation to the airway wall through a dedicated catheter.
COVID-19 Impact on Global Bronchial Thermoplastic Catheter Market
The COVID-19 pandemic negatively impacted the bronchial thermoplasty catheter market as hospitalization rate for asthma cases decreased during the COVID-19 pandemic and only for severe illnesses, patients were admitted to the hospitals. Also, there are very few companies in the market that offer bronchial thermoplasty catheters. In addition, COVID-19 virus majorly impacts the respiratory system. Hence, patients diagnosed with COVID-19 were hospitalized for its treatment and asthma-related hospitalizations were declined. As bronchial thermoplasty catheter system is used to treat patients with severe asthma, its demand decreased during the pandemic. Asthmatic patients must remain cautious throughout the COVID-19 pandemic, taking all steps to stay safe. A deeper knowledge of asthmatic exacerbation and its connection to COVID-19 should be part of future initiatives. Because of this new condition, healthcare services had to adjust, including reallocating people and supplies as well as changing management standards. A significant problem is to avoid exposing patients and healthcare personnel to the danger of infection and act on increasing the availability of personal protective equipment.
Growing Pollution and People's Susceptibility to Dust Allergy Projected to Drive Market Growth
Airway remodeling in severe asthma comprises increase in airway smooth muscle mass, which is linked with reduced lung function, airway hyper responsiveness, and poor symptom management. Bronchial thermoplasty lowers the quantity of airway smooth muscle in experimental animals, patients with bronchial cancer awaiting lung resection, and people with asthma. There is contradictory evidence about whether reduced airway smooth muscle mass is connected with improved clinical outcomes following bronchial thermoplasty catheters.
Increasing pollution is hazardous to asthma patients because dust mites damage the health of those with asthma and those who are allergic or sensitive to mites. These allergens can cause mild to severe allergic reactions and asthma attacks. Most people prefer a bronchial thermoplasty catheter procedure for asthma disease recovery.
To know more about global bronchial thermoplasty catheter market drivers, get in touch with our analysts here.
Need of Skilled Operators and Developed Infrastructure in Bronchial Thermoplastic Catheters to Restrain Market Growth
As a therapy for people with severe asthma, bronchial thermoplasty may be provided, and it works effectively for asthma patients. Bronchial thermoplasty (BT) is a new therapeutic option for people with asthma who have not responded to standard medication. BT is an intrusive technique that can cause coughing, wheezing, bronchospasm, and laryngospasm both, during and after the operation. The important challenges to BT services are a lack of bronchial thermoplasty service providers in rural and urban areas and a shortage of skilled workers. Rural populations face a variety of challenges when it comes to healthcare services, making it difficult for them to receive the treatment they need. The healthcare industry's growth is hampered by a number of factors, including the high cost of bronchial thermoplasty catheter services. The primary impediment to the bronchial thermoplasty catheter market revenue growth is a lack of skilled professionals as a result of a lack of relevant skills.
Globally Rising Cases of Asthma to Drive Excellent Opportunities in the Market
Asthma incidence has risen in tandem with the frequency of other allergens, such as allergic rhinitis and eczema. Asthma incidence and prevalence patterns differ between children and adults. Asthma commonly begins in childhood; however, it can occur at any age, with some people experiencing asthma for the first time as adults. Prepubertal males have a higher incidence, prevalence, and hospitalization rate for asthma than prepubertal females. This pattern may reverse through adolescence. Additionally, the need for bronchial thermoplasty catheter services is growing significantly as the elderly population increases. To ensure that the elderly population receives end-to-end bronchial thermoplasty catheters, service providers concentrate on all aspects of hospital settings. For instance, in August 2021 the U.S. Food and Drug Administration (FDA) approved the Boston Scientific Corporation EXALT Model B Single-Use Bronchoscope, which is designed to treat wide range of bronchoscopy procedure such as airway intubation, secretion management, percutaneous tracheostomy, double lumen endotracheal tube placement and biopsies.
To know more about global bronchial thermoplasty catheter market opportunities, get in touch with our analysts here.
Global Bronchial Thermoplasty Catheter Market, By End User
By end user, the market has been divided into hospitals and ambulatory surgery centers. Among these, the ambulatory surgery centers segment accounted for the highest market share in 2021 whereas the hospitals segment is estimated to show the fastest growth during the forecast period.
Global Bronchial Thermoplasty Catheter Market Size, by End User, 2021
Source: Research Dive Analysis
The ambulatory surgery centers segment accounted a dominant market share in 2021. Ambulatory surgery centers (ASCs) are medical clinics that specialize in outpatient surgical services. Outpatient refers to a patient who is not admitted to a hospital and may leave on the same day of the surgery. Patients who choose to have surgery in an ASC arrive on the day of the procedure, have the surgery in a fully equipped operating room, and recover under the supervision of highly competent nurses, all without the need for hospitalization. Patients and their families benefit from the comfortable environment provided by ASCs, whether patients are young, elderly, or somewhere in between.
The hospitals segment is anticipated to show the fastest growth by 2031. Greater healthcare substructure, the availability of a skilled workforce, and the cost-effectiveness of the materials used to make catheters are all reasons that are causing this market to grow. Another factor that influenced the growth of the bronchial thermoplasty catheter market is a significant growth in the geriatric population suffering from unhealthy lifestyles including asthma, which is expected to boost the growth of hospital segment.
Global Bronchial Thermoplasty Catheter Market, Regional Insights
The bronchial thermoplasty catheter market was analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Global Bronchial Thermoplasty Catheter Market Size & Forecast, by Region, 2021-2031 ($ Million)
Source: Research Dive Analysis
The Bronchial Thermoplasty Catheter Market in North America to be the Most Dominant
The North America bronchial thermoplasty catheter market size accounted a dominating market share in 2021. The demand for bronchial thermoplasty catheter in the North America region is rising due to use of automobiles as well as government rules for reducing vehicle accidents, which is creating opportunities for the bronchial thermoplasty industry. Increasing asthma attacks among individuals, increase in the number of hospitalizations of asthma patients in the U.S., the presence of major players, and rapid technological advancements are some of the factors that have contributed to the growth of the bronchial thermoplasty market in the North American region. Because of its high adoption of technically advanced treatment devices and processes, North America is expected to have the largest share of the global market during the forecast period. Even though this is a new method, a large number of public and commercial healthcare payers are considering reimbursement for these treatments on a case-by-case basis. These factors are increasing the development of bronchial thermoplasty catheter in region
Competitive Scenario in Global Bronchial Thermoplasty Catheter Market
Investment and agreement are common strategies followed by major market players. For instance, Boston Scientific Corporation acquired Asthmatx, Inc., a manufacturer of the Alair system, in 2010. This system was approved by the FDA in the U.S. in April 2010 and by the CE Mark in 2011.
Source: Research Dive Analysis
Currently Boston Scientific is the only manufacturing company in the bronchial thermoplasty catheter market.
Historical Market Estimations
Base Year for Market Estimation
Forecast Timeline for Market Projection
North America, Europe, Asia-Pacific, and LAMEA
Segmentation by End User
Key Companies Profiled
Q1. What is the size of the global bronchial thermoplasty catheter market?
A. The size of the global bronchial thermoplasty catheter market was over $3409 million in 2021 and is projected to reach $5416.8 million by 2031.
Q2. Which are the major companies in the bronchial thermoplasty catheter market?
A. Boston Scientific is the key player in the global bronchial thermoplasty catheter market.
Q3. Which region, among others, possesses greater investment opportunities in the near future?
A. The North America region possesses great investment opportunities for investors to witness the most promising growth in the future.
Q4. What will be the growth rate of the North America bronchial thermoplasty catheter market?
A. North America bronchial thermoplasty catheter market is anticipated to grow at a CAGR 4.99% during the forecast period.
Q5. What are the strategies opted by the leading players in the market?
A. Agreement and investment are the two key strategies opted by the operating companies in this market.
Q6. Which companies are investing more on R&D practices?
A. Boston Scientific is investing more on R&D activities for developing new products and technologies.
1.2.Real time insights and validation
1.4.Assumptions and forecast parameters
1.5.Market size estimation
2.2.Key objectives of the study
2.5.Overview of the impact of COVID-19 on Global Bronchial Thermoplasty Catheter Market
4.2.Growth impact forces
4.3.Market value chain analysis
4.3.1.List of raw material suppliers
4.3.2.List of manufacturers
4.3.3.List of distributors
4.4.Innovation & sustainability matrices
4.5.Porter’s five forces analysis
4.5.1.Bargaining power of suppliers
4.5.2.Bargaining power of consumers
4.5.3.Threat of substitutes
4.5.4.Threat of new entrants
4.5.5.Competitive rivalry intensity
4.7.Impact of COVID-19 on Bronchial Thermoplasty Catheter Market
4.7.1.Pre-covid market scenario
4.7.2.Post-covid market scenario
5.Bronchial Thermoplasty Catheter Market Analysis, by End User
5.2.1.Definition, key trends, growth factors, and opportunities
5.2.2.Market size analysis, by region, 2021-2031
5.2.3.Market share analysis, by country, 2021-2031
5.3.Ambulatory Surgery Centers
5.3.1.Definition, key trends, growth factors, and opportunities
5.3.2.Market size analysis, by region, 2021-2031
5.3.3.Market share analysis, by country, 2021-2031
5.4.Research Dive Exclusive Insights
6.Bronchial Thermoplasty Catheter Market, by Region
18.104.22.168.Market size analysis, by End User
22.214.171.124.Market size analysis, by End User
126.96.36.199.Market size analysis, by End User
6.1.4.Research Dive Exclusive Insights
188.8.131.52.Market size analysis, by End User
184.108.40.206.Market size analysis, by End User
220.127.116.11.Market size analysis, by End User
18.104.22.168.Market size analysis, by End User
22.214.171.124.Market size analysis, by End User
6.2.6.Rest of Europe
126.96.36.199.Market size analysis, by End User
6.2.7.Research Dive Exclusive Insights
188.8.131.52.Market size analysis, by End User
184.108.40.206.Market size analysis, by End User
220.127.116.11.Market size analysis, by End User
18.104.22.168.Market size analysis, by End User
22.214.171.124.Market size analysis, by End User
6.3.6.Rest of Asia-Pacific
126.96.36.199.Market size analysis, by End User
6.3.7.Research Dive Exclusive Insights
188.8.131.52.Market size analysis, by End User
184.108.40.206.Market size analysis, by End User
220.127.116.11.Market size analysis, by End User
18.104.22.168.Market size analysis, by End User
6.4.5.Rest of LAMEA
22.214.171.124.Market size analysis, by End User
6.4.6.Research Dive Exclusive Insights
7.1.Top winning strategies, 2021
7.3.Market share analysis, 2021
9.1.Parent & peer market analysis
9.2.Premium insights from industry experts
With significant developments in inhalational therapy in the recent years, a majority of asthma patients may look forward to a healthy life with few symptoms and few exacerbations—as long as their drug is utilized and used correctly. Nevertheless, despite routine preventative therapy, there are still a small number of people with persistent, serious diseases. Bronchial thermoplasty (BT) was created as an add-on therapy for these more severe diseases like asthma.
Bronchial thermoplasty is an advanced treatment for asthma, the world's leading chronic disease. Asthma is one of the most common chronic disorders in children, and it deteriorates with age. It is a complex inflammatory condition brought on by environmental causes or genetic mutations. In asthma, the airway muscles become overly sensitive to different allergens, which causes inflammation of the airway tract's muscular wall and, as a result, narrows the airway channel. Inflammation eventually causes the smooth muscles in the airway tract to thicken, which restricts airflow and interferes with breathing. Asthma is treated by giving patients a variety of medications, such as steroids, beta-agonists, and ibuterol through nebulizers and inhalers. However, bronchial thermoplasty is advised in extreme circumstances, where managing asthma with these drugs is less successful. The global bronchial thermoplasty catheter market is expanding at a rapid pace due to increasing air pollution and the prevalence of dust allergies among people across the globe.
Newest Insights in the Bronchial Thermoplasty Catheter Market
An increase in asthma attacks among people, as well as an increase in the number of hospitalizations for asthma patients have triggered advancements in the field of bronchial thermoplasty catheters. As per a report by Research Dive, the global bronchial thermoplasty catheter market is expected to surpass a revenue of $5,416.8 million in the 2022-2031 timeframe. The North America bronchial thermoplasty catheter market is expected to perceive dominant growth in the years to come. This is because the region has a gigantic demand for bronchial thermoplasty catheters owing to the usage of automobiles as well as government restrictions aimed at decreasing vehicle accidents, which is creating prospects for the bronchial thermoplasty catheter market in the region.
How are Market Players Responding to the Rising Demand for Bronchial Thermoplasty Catheters?
Presently, Boston Scientific is one of the leading manufacturers in the bronchial thermoplasty catheter market. The company is greatly investing in pioneering research and inventions to cater for the rising demand for bronchial thermoplasty catheters. It is focused on planning and devising tactics such as mergers and acquisitions, collaborations, novel advances, and partnerships to reach a notable position in the global market. Apart from this, several other companies have made significant developments in the bronchial thermoplasty catheter arena in the recent years.
- In April 2021, Olympus Corporation, a leader in medical technologies worldwide, announced the addition of the 510(k)-cleared H-SteriScope Single-Use bronchoscopes, a range of 5 premium endoscopes used for cutting-edge diagnostic and therapeutic procedures, to its U.S. bronchoscopy portfolio.
- In January 2023, Apollo Multispecialty Hospitals Kolkata, one of the top hospitals offering advanced treatment, introduced bronchial thermoplasty, a painless method for the efficient treatment of chronic asthma, for the first time in Eastern India.
COVID-19 Impact on the Global Bronchial Thermoplasty Catheter Market
The unpredicted rise of the coronavirus pandemic in 2020 has adversely impacted the global bronchial thermoplasty catheter market. During the pandemic period, the hospitalization rate for asthma cases was reduced, and only individuals with serious symptoms were admitted. Furthermore, there were just a few companies on the market who provide bronchial thermoplasty catheters. Asthmatic patients took all necessary precautions to stay safe amidst the COVID-19 pandemic. The respiratory system had a great impact of the COVID-19 virus. As a result, patients with COVID-19 infection were hospitalized for treatment, whereas admissions for asthma were declined. The demand for bronchial thermoplasty catheter systems declined during the pandemic since it is used to treat individuals with severe asthma. However, the global market is likely to gain traction post-pandemic crisis, with rising developments in the coming years.